期刊
TISSUE ENGINEERING PART A
卷 20, 期 9-10, 页码 1499-1507出版社
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.tea.2013.0263
关键词
-
资金
- [R21 HL107768-01A1]
- [R01 HL083895-06A1]
- [1P01HL107205-01A1]
Tissue-engineered small-diameter vascular grafts have been developed as a promising alternative to native veins or arteries for replacement therapy. However, there is still a crucial need to improve the current approaches to render the tissue-engineered blood vessels more favorable for clinical applications. A completely biological blood vessel (3-mm inner diameter) was constructed by culturing a 50:50 mixture of bovine smooth muscle cells (SMCs) with neonatal human dermal fibroblasts in fibrin gels. After 30 days of culture under pulsatile stretching, the engineered blood vessels demonstrated an average burst pressure of 913.3 +/- 150.1mmHg (n=6), a suture retention (53.3 +/- 15.4g) that is suitable for implantation, and a compliance (3.1%+/- 2.5% per 100mmHg) that is comparable to native vessels. These engineered grafts contained circumferentially aligned collagen fibers, microfibrils and elastic fibers, and differentiated SMCs, mimicking a native artery. These promising mechanical and biochemical properties were achieved in a very short culture time of 30 days, suggesting the potential of co-culturing SMCs with fibroblasts in fibrin gels to generate functional small-diameter vascular grafts for vascular reconstruction surgery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据